138 results about "General anaesthesia" patented technology

In various exemplary embodiments, the present invention provides a plurality of novel interspinous distraction devices and associated methods of insertion. The interspinous distraction devices of the present invention are designed and configured to effectively treat such conditions as lumbar spinal stenosis and degenerative disc disease. Advantageously, the interspinous distraction devices of the present invention may be inserted through conventional open procedures, typically requiring a relatively large incision and a general anesthetic, or through novel minimally-invasive procedures, typically requiring only a local anesthetic. These novel minimally-invasive procedures and related enabling devices are also disclosed and described herein.

A method and apparatus to monitor the neurologic state of a patient undergoing general anesthesia is provided. Previous automated systems to monitor the neurologic state of a patient undergoing general anesthesia involve a significant time delay between the patient's true hypnotic state and the computed indices. The present invention reduces this time delay by using a different analysis technique applied to spontaneous EEG. A wavelet decomposition and statistical analysis of the observed EEG is conducted and compared to reference data to provide a numerical indicator. In addition, this indicator is more consistent with the patient's loss of consciousness indicated by the loss of count event than previous systems.

A method and system for objectively scoring intra-operative pain during general anaesthesia based on the patient's mean arterial pressure and heart rate. The index is used for closed-loop control of the intra-operative analgesia through adjustment of the drug infusion level according to fuzzy logic. It is further displayed along with other components of anaesthesia and important patient data on a monitoring display for presentation to medical staff.

An airway device used to establish an airway in an unconscious person or person receiving general anesthesia. The device is composed of a gas tube with a breathing circuit connector on one end and an endplate on the other. The present art incorporates a guide cord, guide loops or conduits, a pull-ring, endplate creases, tubular notches and geometric gas tube designs. Specifically, the guide cord is attached to the endplate tip and routed through the endplate and gas tube by means of the guide loops or conduits. The guide cord exits near the gas tube connector and terminates to a pull-ring. The guide cord conveys pull-ring manipulation to the endplate and permits change of endplate attitude and shape and prevents endplate fold back. Also, endplate creases, gas tube notches and geometric gas tube designs are applied to optimize insertion and safety of the device.

Methods and compositions for agonizing a type-2 orexin receptor (OX2R) in a cell determined to be in need thereof, including the general method of (a) administering to a subject a cyclic guanidinyl OX2R agonist and (b) detecting a resultant enhanced wakefulness or increased resistance to diet-induced accumulation of body fat, or abbreviated recovery from general anesthesia or jet lag.

Disclosed is drug delivery for facilitating medical and / or procedures that are performed without “general anesthesia,” which is also described in the specification as the state of patient “unconsciousness” resulting from a drug administered by an anesthetist or anesthesiologist. Mixtures of sedative and analgesic drugs are adapted for safe and effective administration by devices to provide and maintain drug infusions that do not push the patient into unconsciousness and / or general anesthesia. Drug delivery devices are also disclosed that include the use of stored parameters and / or values that correlate to drug mixture delivery during a procedure, and a patient health monitor to measure and send signals regarding a patient health condition to a processor.

Described are equipment, a system, a kit and a method for the performance of a minimally-intensive body access, such as cardiac access. Epicardial Access Surgery (EAS) is disclosed. EAS does not need general anesthesia or extracorporeal circulation nor does it need a chest opening, which is very advantageous for various aspects. For instance an operation of a coronary artery bypass is created by creating a direct path of flow from one body artery into a coronary artery with the aid of catheter-based minimally-invasive EAS based bypass surgery. In addition, various medical devices are used, such as a special partially flexible needle, a special partially covered stent, and a special partially flexible port.

A method and apparatus are provided for ventilation of patients during general anesthesia. Breathing gas is supplied to the patient during anesthesia at a controlled volume above the functional residual capacity of the patient's lungs. The patient is allowed to spontaneously respire when the volume of breathing gas is above the functional residual capacity. The pressure of the breathing gas is periodically reduced to facilitate expulsion of carbon dioxide-containing gas from the patient. The system promotes alveolar ventilation, carbon dioxide excretion, oxygenation and respiratory monitoring in patients who receive general anesthesia.

Disclosed are methods for facilitating medical and / or procedures that are performed without “general anesthesia,” which is also described in the specification as the state of patient “unconsciousness” resulting from a drug administered by an anesthetist or anesthesiologist. The methods safely and effectively provide and maintain drug infusions that do not push the patient into unconsciousness and / or general anesthesia. Methods according to certain embodiments of the invention include the use of parameters and / or values that correlate to drug delivery during a procedure, and a patient health monitor to measure and send signals regarding a patient health condition to a processor.

In various embodiments, the present invention provides a plurality of novel interspinous distraction devices and associated methods of insertion. The interspinous distraction devices of the present invention are designed and configured to effectively treat such conditions as lumbar spinal stenosis and degenerative disc disease. Advantageously, the interspinous distraction devices of the present invention may be inserted through conventional open procedures, typically requiring a relatively large incision and a general anesthetic, or through novel minimally-invasive procedures, typically requiring only a local anesthetic. These novel minimally-invasive procedures and related enabling devices are also disclosed and described herein.

Methods and compositions for agonizing a type-2 orexin receptor (OX2R) in a cell determined to be in need thereof, including the general method of (a) administering to a subject a cyclic guanidinyl OX2R agonist and (b) detecting a resultant enhanced wakefulness or increased resistance to diet-induced accumulation of body fat, or abbreviated recovery from general anesthesia or jet lag.

A method and apparatus to monitor the neurologic state of a patient undergoing general anesthesia is provided. Previous automated systems to monitor the neurologic state of a patient undergoing general anesthesia involve a significant time delay between the patients true hypnotic state and the computed indices. The present invention reduces this time delay by using a different analysis technique applied to spontaneous EEG. A wavelet decomposition and statistical analysis of the observed EEG is conducted and compared to reference data to provide a numerical indicator. In addition, this indicator is more consistent with the patient's loss of consciousness indicated by the loss of count event than previous systems.

The invention refers to a method and apparatus for changing the concentration of a target gas at the blood compartment of a patient's lung from an actual target gas concentration to a desired target gas concentration during artificial ventilation with an inspiratory gas composition by a respirator being controlled via a set of ventilation parameters. In order to decrease the negative effects of general anaesthesia during artificial ventilation even further, the method according to the invention comprises the following steps: a) ventilating the lung in a first ventilation stage, and b) ventilating the lung in a second ventilation stage in which alveolar recruitment is promoted.

The present invention provides for a unique modification of the intravenous catheter, attached to the terminal line of the mass spectrometer and the use of a disposable nasal oxygen cannula provide an effective and efficient port to monitor end tidal carbon dioxide (PETCO2) in unintubated, conscious, spontaneously breathing patients who are receiving administration of local and regional anesthesia or during recovery from residual general anesthesia.

A portable neuromuscular stimulator is disclosed. The neuromuscular stimulator for use with a patient during general anesthesia comprises a housing, a pair of electrode terminals disposed on the outside of the housing, a pulse generator within the housing, wherein the pulse generator is disposed to controllably generate one of TOF and Tetanus stimulations to the electrode terminals, and the pulse generator having an intensity controller to controllably vary the level of intensity of the stimulations. The stimulator also has a liquid crystal display (“LCD”) on the outside of the housing, with the LCD being disposed to display a mode of operation and a level of intensity representative of the stimulation being applied to the electrode terminals from said pulse generator.

In various exemplary embodiments, the present invention provides a plurality of novel interspinous distraction devices and associated methods of insertion. The interspinous distraction devices of the present invention are designed and configured to effectively treat such conditions as lumbar spinal stenosis and degenerative disc disease. Advantageously, the interspinous distraction devices of the present invention may be inserted through conventional open procedures, typically requiring a relatively large incision and a general anesthetic, or through novel minimally-invasive procedures, typically requiring only a local anesthetic. These novel minimally-invasive procedures and related enabling devices are also disclosed and described herein.

A device and method for stimulating nerves. In one application, the approaches treat nausea and vomiting caused by a reaction to general anesthesia. A bi-modal approach involving acustimulation and medicants is contemplated for specific conditions.

This invention relates to a novel pharmaceutical composition which may be administered parenterally to a mammal for the production of general anaesthesia, specifically to a limpid, stable, injectable pharmaceutical formulation of 2,6-diisopropylphenol. The formulation comprises 2,6-diisopropylphenol, a compound of the following general formula (I) wherein R1 and R2 can be the same or different and are hydrogen or lower alkyl group containing 1-3 carbons or acetate group and optionally water and / or one or more antioxidants.

A system and method for monitoring and / or controlling a state of consciousness of a subject experiencing anesthesia are provided. In some aspects, the system includes a plurality of sensors placed about the subject and configured to acquire electroencephalogram (“EEG”} data therefrom while the subject is receiving anesthesia, and at least one processor configured to receive the EEG data from the plurality of sensors, and perform a phase-amplitude coupling analysis using the received EEG data to determine a phase-amplitude frequency distribution. The at least one processor is also configured to identify a state of consciousness of the subject using the determined phase-amplitude frequency distribution, and generate a report indicative of the state of consciousness of the subject.

The present invention disclosed a device and method for assessing in real time the hypnotic and analgesic effect in a subject during wakefulness, sedation and general anaesthesia via drug interactions and physiological signals. In a preferred embodiment of the present invention, the analgesic and hypnotic effect of drug(s) infused in a subject could be accurately assessed in real time through the device and method disclosed in the present invention, comprising steps of receiving data from electroencephalography (EEG) device, receiving data from brain impedance tomography device, obtaining pharmacodynamic and pharmacokinetic parameters of drug(s) infused in the subject, defining initial indices of consciousness and nociception as a function of said EEG and brain impedance tomography data, and generating output of final indices of consciousness and nociception in real time from processing input of EEG, brain tomography and drug interaction data using established mathematical manipulation.

A controllable intubating stylet (CIS) for use by anesthesia and other health care providers is used in conjunction with a video laryngoscope and endotracheal tube in order to achieve intubation of the trachea for general anesthesia as well as other medical conditions. The video laryngoscope is used to visualize the tracheal opening. The CIS is inserted into an endotracheal tube and directed into the trachea. The endotracheal tube then is maneuvered over the stylet and into the trachea, and thereafter, the CIS is removed. The patient can then be oxygenated and ventilated by way of the endotracheal tube. The CIS includes a control mechanism similar to current bronchoscopes which allows for flexion of the tip and overall flexibility of the stylet. In contrast to the bronchoscope, however, the CIS includes no fiberoptics or associated components, such as a light source or eyepiece, making the CIS much less expensive to produce.

A system and method are presented for treating branches of the superior hemorrhoidal artery by photocoagulation using laser energy. The inflamed dilated blood vessels in and around the anal region, often called hemorrhoids or piles, are caused due to a connective tissue disorder, a relative increase in pressure in the superior hemorrhoidal artery and a weakening of the vessels' valves. A suitable treatment system and a method are given for treating such conditions in a minimally invasive manner. The treatment system photocoagulates the branches of a superior hemorrhoidal artery in the anal and rectal regions using laser energy while causing minimal pain or discomfort to the patient. The system is provided with a transparent operational window. The distal end of the fiber and Doppler system channel are at the operational window. The system also includes a viewing window. The post operative recovery is faster than alternative approaches with no complications. In contrast to most other successful methods of the prior art, general anesthesia is no longer required, thereby significantly reducing complications and simplifying treatment.

An inflatable oral airway (IOA) device for maintaining the patency of an airway of a patient without substantial extension into the pharynx or larynx of the patient. The IOA is inserted into the patient's oro-pharynx after the patient is sedated or under general anesthesia. The IOA comprises a core that is substantially shaped the same as a conventional or normal human airway. The IOA has an inverted orientation, i.e. the bottom or ventral surface of the core rests on the upper surface of the patient's tongue. The IOA also comprises a cuff and a hinge balloon which may be inflated in tandem or in sequence to open and support the soft tissues of the mouth and pharynx in four different directions as well as articulate and increase the internal volume of the IOA itself.

The embodiments herein provide a maxillary protraction device is provided for treating Maxillary Transverse Discrepancies in young orthodontic patients and in skeletally mature patients using only local anesthesia and without administering general anesthesia. The maxillary protraction device comprises a hyrax provided with an adjustable screw and a plurality of bands connected to the hyrax through a connecting wire. A tongue plate is connected to the hyrax through the connecting wire. A tongue sprue wire is provided and soldered to an anterior segment of a premolar band to reinforce the tongue plate. The connecting wire holds the tongue plate in a position to resist a tongue pressure. The physiological tongue forces produced during swallowing are used to move the maxilla in forward, sagittal and vertical directions. The parasagittal osteotomy is employed to reposition the individual segments in a widened transverse dimension, and to facilitate 3-dimensional movements of the maxilla.

The invention relates to a portable anesthesia combined-type device which belongs to the technical field of medical appliances. The portable anesthesia combined-type device provided by the invention comprises an anesthetic low-temperature storage box and an anesthesia equipment storage cabinet, wherein an anesthetic storage hand-lifting box is disposed in the anesthetic low-temperature storage box; a hand-lifting box handle is disposed on the upper side of the anesthetic storage hand-lifting box; a hand-lifting box limiting fixation ring is disposed on the outer side of the anesthetic storage hand-lifting box; a switch combined-type disk is disposed on the front side of the anesthetic low-temperature storage box; a combined-type disk protective cover is disposed on the left side of the switch combined-type disk; the combined-type disk protective cover is connected to the switch combined-type disk by a protective cover hinge; a protective cover lateral-opening handle is disposed on the left side of the combined-type disk protective cover; a temperature display screen is disposed on the right upper side of the switch combined-type disk; a temperature adjustment knob is disposed on the switch combined-type disk; and a storage cabinet sterilization switch is disposed on the lower side of the temperature adjustment knob. The device provided by the invention has the advantages that functions are complete; utilization is convenient; and during general anesthesia or local anesthesia of a patient, operations are scientific and effective, time and efforts are saved, and workloads of medical workers are greatly reduced.

An anti-hypothermia composition is provided, in particular an anti-hypothermia composition that prevents hypothermia caused by general anesthesia during surgical operations. The composition prevents hypothermia by preventing the decrease in the biological function of patients and correcting acidosis. Specifically, the anti-hypothermia composition is a preparation containing a bicarbonate ion and provided in the form of an infusion fluid. The infusion fluid preferably contains sodium bicarbonate as a major component that serves as a source of the bicarbonate ion, along with each or a combination of other electrolytes, glucose and amino acids.

An eye cover is provided that attaches to an air pump that provides a constant high humidity environment to the eyes, and protects the eyes especially during periods of anesthesia.

Disclosed is a tracheal intubation tube fixing device for securing an airway in the patient's respiratory tract and inducing the artificial respiration of a patient in the intensive care unit or under a general anesthesia operation. The device includes a body to surround the patient's face and mouth and including an airway securing block, a suction tube insertion opening, an intubation tube insertion hole and band fixing holes, a pivotal fixing member to fix an inserted intubation tube, a coupling structure to assure free entrance and exit of the pivotal fixing member into and out of the intubation insertion hole, a padding member attached to Velcro tapes of the body, and a holding member configured to closely surround the patient's rear neck and coupled to the body via the band fixing holes to prevent the body from being moved from a wearing position thereof.

D-Ribose is administered before and after general anaesthesia to reduce the time to recover from the effects of general anaesthesia. Preferably, pyrogen-free D-Ribose is administered intravenously during general anaesthesia and the interval post-anaesthesia before oral administration can be resumed. D-Glucose may be co-administered to reduce the effect of hypoglycemia that may be seen with D-Ribose administration.

An apparatus for reversing inhaled anesthesia, which is configured to be positioned along a breathing circuit or anesthesia delivery circuit, includes a filter for removing one or more anesthetic agents from gases passing therethrough, as well as a component for elevating CO2 levels in gases that are to be inhaled by an individual. The apparatus is configured to be positioned between a Y-connector of the breathing circuit and the portion of the breathing circuit that interfaces with the individual. The CO2 level-elevating component facilitates an increase in the ventilation of the individual without resulting in a significant decrease in the individual's PaCO2 level and, thus, a decrease in the rate at which blood flows through the individual's brain. A method of reversing the effects of inhaled anesthesia includes increasing the rate of ventilation of an anesthetized individual while causing the individual to inhale gases with elevated amounts of CO2 and while filtering anesthetic agents from such gases.